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Background: Hyaluronidases have been found as the target enzymes in the development of osteoarthritis (OA)
disease. While there is still no curative treatment for this disease, recent studies on the treatment of OA were
focused on the effectiveness of natural products which are expected to improve the symptoms with minimal side
effects. The aim of this study was to screen selected Malaysian plants on their anti-hyaluronidase activity as well as
to evaluate the active plant and its derived fractions on its potential anti-arthritic and antioxidant activities.
Methods: A total of 20 methanolic crude extracts (bark and leaf) from ten different plants were screened using a
colorimetric hyaluronidase enzymatic assay. The active plant extract (Payena dasyphylla) was then studied for its
hyaluronidase inhibitory activity in the interleukin-1β (IL-1β) stimulated human chondrocytes cell line (NHAC-kn)
using zymography method. The Payena dasyphylla methanolic bark extract was then fractionated into several
fractions in where the ethyl acetate (EA) fraction was evaluated for its inhibitory effects on the HYAL1 and HYAL2
gene expressions using reverse transcription-polymerase chain reaction (RT-PCR) technique. While the MMP-3 and
MMP-13 protein expressions were evaluated using western blot method. The phenolic and flavonoid contents of
the three fractions as well as the antioxidant property of the EA fraction were also evaluated.
Results: Bark extract of Payena dasyphylla (100 μg/ml) showed the highest inhibitory activity against bovine
testicular hyaluronidase with 91.63%. The plant extract also inhibited hyaluronidase expression in the cultured
human chondrocyte cells in response to IL-1β (100 ng/ml). Similarly, treatment with Payena dasyphylla ethyl acetate
(EA) fraction (100 μg/ml) inhibited the HYAL1 and HYAL2 mRNA gene expressions as well as MMP-3 and MMP-13
protein expression in a dose dependent manner. Payena dasyphylla EA fraction has demonstrated the highest
amount of phenolic and flavonoid content with 168.62 ± 10.93 mg GAE/g and 95.96 ± 2.96 mg RE/g respectively as
compared to water and hexane fractions. In addition, the Payena dasyphylla EA fraction showed strong antioxidant
activity with IC50 value of 11.64 ± 1.69 μg/mL.
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Conclusion: These findings have shown that Payena dasyphylla might contained potential phenolic compounds
that inhibiting the key enzyme in osteoarthritis development, which is the hyaluronidase enzyme through
interruption of HYAL1 and HYAL1 gene expressions. The degradation of cartilage could also be inhibited by the
plant through suppression of MMP-3 and MMP-13 protein expressions. We also reported that the inhibitory effect
of Payena dasyphylla on hyaluronidase activity and expression might be due to its anti-oxidant property.
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Joint related diseases such as arthritis, contributes a
large segment of an orthopaedic’s caseload. Arthritic dis-
eases interfere with our daily activities as it causes enor-
mous burdens in terms of pain, crippling and disability.
Osteoarthritis (OA), the most common form of arthritis
is the leading cause of chronic disability at older age. It
is estimated that the prevalence of symptomatic knee
OA in population above the age of 65 is 30 % and
women suffer from knee OA two times higher than
men. OA is characterized by a slow progressive degener-
ation of articular cartilage that leads to joint signs and
symptoms, including changes at the subchondral bone
and synovium. OA commonly affects the hands, spine,
knees and hips [1] with other joints such as the wrist, el-
bows, and shoulders less frequently involve. While all
tissues involving the synovial joint are affected, the de-
generation of articular cartilage is the main pathological
feature in this disease. The breakdown of articular cartil-
age in OA may start as a focal lesion and progressively
extend to involve multiple components of the synovial
joints such as alteration in the bone underneath the car-
tilage, development of marginal outgrowths, osteophytes
and increased thickness of subchondral bone [2].
Research has proven that although age is the substantial
risk factor for the account of this disease, other factors are
also known to affect the progression of OA which includes
obesity, mechanical factors such as trauma or injury to the
joint [1] and genetic abnormalities [3]. However, the exact
pathogenesis of this disease is still poorly understood. But
latest detection methods showed that OA does not only
result from the breakdown of articular cartilage due to
aging and biomechanical factors, but is also caused by ele-
vated levels of hydrolytic enzymes activity [4,5]. Hyaluron-
idase or hyaluronate glycanohydrolase (EC 3.2.1.35) is
large neglected class of hydrolytic enzymes that belongs to
the family of degradative endoglucosaminidase. This en-
zyme was found to be one of the most predominant glyco-
sidase present during cytokine-induced ECM degradation
associated with the synovial joint disease [6]. Hyaluroni-
dase is also widespread in nature, which present abun-
dantly in mammals, insects, leeches and bacteria [7,8].
Hyaluronan or hyaluronic acid (HA), the major building
blocks of the matrix components in the ECM aredegraded upon exposure to free radicals and hyaluro-
nidases (predominantly HYAL1, HYAL2, HYAL3). Hyal-
uronidases break down HA excessively resulting in the
degeneration and gradual loss of articular cartilage leading
to OA.
Besides, destruction of the ECM in cartilage tissue is also
caused by the locally produced matrix metalloproteinases
(MMPs). MMPs are a group of proteases which consists of
collagenases (e.g. MMP-1 and MMP-13), stromelysins (e.g.
MMP-3), gelatinases and membrane type MMPs [9].
MMPs have been implicated in the biophysical degradation
of ECM and the collagenous framework of articular cartil-
age. Activated MMPs are capable of cleaving most of the
components in the ECM including type II collagen and
aggrecan. Stromelysin-1 (MMP-3) cleaves proteoglycans
(PGs), collagens, gelatins and link protein of aggrecan,
whereas collagenase-3 (MMP-13) cleaves type II collagen
and aggrecan at particular sites [10]. In cases of degenera-
tive joint disease, such as OA, the expression and synthesis
of both MMP-3 and MMP-13 are increased.
Currently, OA is being treated using conventional thera-
peutic interventions which include drug treatments and
injectable agents such as glucocorticoids and hyaluronan.
Drug therapies although costly, have extensively being
used in mild to moderate cases where the use of drug
treatments is to control pain and prolong disease progres-
sion. Although drug medication have proven to be effect-
ive in controlling pain, the prolong use of this drugs have
been associated with serious adverse effects, mainly ulcer
formation and gastrointestinal complications [11]. Hence,
there appears to be a need for drugs with low toxicity and
effective in the treatment of OA. Therefore, patients are
turning increasingly to alternative medications.
The uses of natural products in treating such diseases
have been gaining attention due to reasons such as they
are found in nature and safer. Furthermore, report on
incidences of adverse effects from consumption of nat-
ural products seems low as it may provide a much
needed alternative for patients with long-term chronic
OA [12]. Hence, in this project Payena dasyphylla a se-
lected Malaysian tree locally known as “nyatoh” has been
studied for its inhibitory effect on hyaluronidase enzyme
activity and MMPs protein expressions as well as its
anti-radical scavenging activity.
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Plant materials and preparation of extracts
All plant materials were collected from the Sekayu forest
reserve, Terengganu, east peninsular of Malaysia. The ten
plant species were identified by botanist, Dr. Shamsul
Khamis from Institute of Bioscience, Universiti Putra
Malaysia (UPM) and the voucher specimen numbers of
the collected plant samples were deposited in the Herbar-
ium, Biodiversity Unit, Institute of Bioscience, UPM. The
methanolic crude extracts of the ten plants (bark and leaf)
were prepared using a standard extraction protocol. Briefly,
samples was first cut into small pieces, dried under the
shade, grounded and macerated in distilled methanol at
room temperature for 48 hours. The extracts were filtered
and the filtrates were collected in a conical flask and kept
aside. The residue was again soaked in a fresh volume of
methanol and the soaking process was repeated 6 times
until clear filtrates were obtained. All the filtrates were then
pooled and evaporated to dryness under reduced pressure.
The extracts were labelled and the yields were recorded
and stored at 4°C prior to use. Plant crude samples were
dissolved in 100% DMSO at concentration of 100 mg/mL
and stored at 4°C prior to experiments.
Hyaluronidase assay
The preliminary screening for the 20 plant samples was
conducted using the colorimetric hyaluronidase enzymatic
assay. Hyaluronidase inhibitory activity was measured
spectrophotometrically according to the Morgan-Elson
method described by Reissig et al., [13] with some modifi-
cations. Briefly, the plant crude samples (100 μg/mL)
dissolved in DMSO were mixed with 250 μL of 2.5 mg/
mL hyaluronan (HA), which dissolved in phosphate buffer
(pH6.4) at 37°C. Then, 100 μL of hyaluronidase (1600 U/
mL) from bovine testis was added and the reaction mix-
ture was incubated for 3 hours at 37°C. After the incuba-
tion period, 50 μL of boric acid was added to the reaction
tube and boiled (100°C) for 15 minutes to stop the reac-
tion. The boiling mixture was then placed on ice and
1 mL of p-dimethylaminobenzaldehyde (DMAB) solution
was added. The reaction tube was then incubated for an-
other 20 minutes at 37°C for the development of max-
imum colorization. The mixture was then transferred into
a 96 well microtiter plate and the absorbance was read at
585 nm by using a microplate reader (SpectraMax, Plus
384, Molecular Devices, Inc., USA).
Cell cultures
Normal human articular chondrocyte derived from the
knee (NHAC-kn) were maintained in a special chondro-
cyte basal medium mixed with 5% fetal bovine serum,
growth factors and supplements (0.2% R3-IGF-1, 0.5%
bFGF, 0.1% transferrin, 0.2% insulin, 0.1% GA-1000) and
grown in a humidified 5% CO2 incubator at 37°C. Thecells were grown in a monolayer culture. Medium was
changed every 2–3 days and the cells were passaged
weekly. Cells of passage number 10–25 were used
throughout the whole research.Zymography
Hyaluronidase expression in the conditioned-media
of NHAC-kn cell culture was analyzed through HA-
substrate zymography according to the protocol de-
scribed by Guntenhoener et al., [14] with slight modifi-
cation. The culture medium of 8 mL was concentrated
10-fold by a membrane filter (Sartorius Stedim Biotech,
Germany) to obtain a detectable amount of hyaluroni-
dase enzyme. Samples that were treated for 24 hours in
the absence or presence of 100 ng/mL of human IL-1β
were loaded and run on a 10% SDS-polyacrylamide gel
containing a final concentration of 0.17 mg/mL hya-
luronan. Following electrophoresis, the gels were incu-
bated in 3% Triton-X 100 solution for 15 minutes with
agitation. The gels were then transferred into 0.1 M so-
dium formate, pH 3.5 containing 0.15 M sodium chlor-
ide (hyaluronidase buffer). Rinsed twice with the buffer
and then incubated at 37°C overnight on a rotating
shaker. After the overnight incubation, the gels were
rinsed with distilled water and stained in 0.5% Alcian
blue solution for 1 hour and destained with 40% ethanol
in 3% acetic acid. Solution was change once every hour
until bands of hyaluronidase were observed. The bands
were imaged using the Versadoc, Bio-Rad imaging sys-
tem and the intensities of the bands were quantified
using the Quantity One program (Bio-Rad).Reverse transcription-polymerase chain reaction (RT-PCR)
NHAC-kn cells were cultured, stimulated and treated in
25 cm2 cell culture flask for 6 hours. The cells were
stimulated with 10 ng/ml of human IL-1β followed by
Payena dasyphylla treatment and all the cells were
harvested for total RNA extraction using RNeasy mini
kit (Qiagen, USA). By using the One-Step RT-PCR kit
(Qiagen, USA), the RNA samples were subjected to RT-
PCR, with selective primers for HYAL1 (5’AGCTGGGA
AAATACAAGAACC-3’ and 5’- TGAGCTGGATGGA
GAAACTGG-3’), HYAL2 (5’- GAGTTCGCAGCACAG
CAGTTC-3’ and 5’- CACCCCAGAGGATGACACC
AG-3’) and GAPDH (5’- TGGTATCGTGGAAGGAC
TCAT-3’ and 5’- GTGGGTGTCGCTGTTGAAGTC-3’).
Primers used were adapted from published gene se-
quences by Flannery et al., [15]. GAPDH functioned as
the internal as well as loading control. The RT-PCR
products were then electrophoresed on an agarose gel
and viewed using the Versadoc, Bio-Rad imaging
system.
Table 1 Effect of 10 selected Malaysian plants (bark and leaf) methanolic extracts on bovine testis hyaluronidase
enzyme inhibitory activity
No. Plants Family Voucher/ Specimen No Bark, % Inhibition Leaf, % Inhibition
1. Agalia densiflorum Meliaceae SK 1562/08 26.14 14.17
2. Agalia macrophylla Meliaceae SK 1563/08 38.71 2.41
3. Dyera costulate Apocynaceae SK 1564/08 8.71 24.70
4. Gnetum cuspidatum Gnetaceae SK 1566/08 35.00 8.26
5. Palaquium gutta Sapotaceae SK 1572/08 88.82 51.35
6. Pauteria obovatta Sapotaceae SK 1577/08 90.47 55.63
7. Payena dasyphylla Sapotaceae SK 1565/08 91.63 24.10
8. Tabernae-montand dichotoma Apocynaceae SK 1573/08 4.05 14.10
9. Uncaria acida Rubiaceae SK 1570/08 37.32 10.50
10 Uncaria villosa Rubiaceae SK 1571/08 55.20 36.97
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Total secreted proteins from 8 mL conditioned medium
of the NHAC-kn cells were concentrated 10-fold by a
membrane filter (Sartorius Stedim Biotech, Germany) to
obtain detectable amount of proteins. Equal volume of
protein (20 μL) samples were incubated for 3 minutes at
95°C in a loading buffer (5 μL), and were separated on a
10% SDS polyacrylamide gel. The gels were run at 40 mA(A)
IL-1β (100 ng/mL) - +
Payena dasyphylla (g/mL) - -






































Figure 1 Effect of Payena dasyphylla methanolic bark extract on the h
zymography result represented from three independent experiments, while
experiment. C; human chondrocytes cells (NHAC-kn) were cultured with m
and treated with Payena dasyphylla bark methanolic extract at 25, 50 and 1
Apigenin (lane 6). Protein extracts prepared from the conditioned-medium
with hyaluronan and electrophoresed. The gels were then stained with Alc
hyaluronidase expression. ***P < 0.001, **P < 0.01 and *P < 0.05 significantly(20 mA per gel, constant current) for 1 hour. After the
separation was completed, the protein bands were electro-
phoretically transferred onto a polyvinylidene diflouride
(PVDF) membrane using TE 77 SemiPhor Semi-dry
Transfer Unit (Amersham Pharmacia Biotech, Amersham,
UK). The transfer process was conducted at constant volt-
age setting (10 V) for exactly 60 minutes. Next, the mem-
brane was incubated with a blocking solution PBST+ + + +
25 50 100 -
- - - 250
25 50 100 (250 M) 
Payena dasyphylla ( g/ml) Apigenin







yaluronidases enzymes expression. Gel image (A) shows the
(B) shows the histogram of hyaluronidases enzyme from the same
edium alone (lane 1), cells induced with IL-1β (lane 2), cells induced
00 μg/mL (lane 3,4 and 5 respectively) and cells induced with
of cultured NHAC-kn were subjected to SDS-PAGE co-polymerized
ian blue staining solution, destained and detected for cellular
different from IL-1β treated control group.
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Figure 2 Histogram shows above is the effect of (A) Payena dasyphylla methanolic bark extract and (B) Payena dasyphylla ethyl acetate
(EA) bark fraction on NHAC-kn cell viability. C; cells were cultured with medium alone and the rest are cells stimulated with 100 ng/ml IL-1β
and treated with increasing concentration of plant extracts for 24 hours as indicated. The absorbance of MTT reduction was measured at a
wavelength of 570 nm and the percentage of cell viability was measured against the control. The values are expressed as mean ± SEM in
triplicates from three independent experiments (n = 3).
Citalingam et al. BMC Complementary and Alternative Medicine 2013, 13:213 Page 5 of 12
http://www.biomedcentral.com/1472-6882/13/213containing 5% serum for 1 hour at 37°C, and then probed
with goat anti-human polyclonal antibodies against MMP-
3 (1:1000) (Abcam, USA) and MMP-13 (1:1000) (Santa
Cruz, USA) separately overnight. Thereafter, membrane
was washed 3 times with three changes of 200 mL of
PBST, with every wash lasting for 10 minutes. This was
followed by subsequent incubation with donkey anti-goat
IgG conjugated with horseradish peroxidase (HRP) (R&D
Systems, USA) secondary antibody (1: 1000) for 1 hour at
room temperature. After incubation, membranes were
washed in five changes of 200 mL of PBST, 10 minutes for
each wash. The bound antibody on the membranewas detected using an enhanced chemiluminescence de-
tection system according to the manufacturer’s manual
(Amersham Pharmacia Biotech, Amersham, UK).
2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
assay
Measurements of radical scavenging assay were carried
out according to the method described by Tagashira and
Ohtake, [16] with slight modification. Stock solution of
the sample was prepared at 100 mg/mL in methanol.
The solution was diluted to different concentrations ran-
ging from 100 to 1.56 μg/mL in a 96-well microtiter
(A)
IL-1β (100 ng/ml) - + + + + +
Payena dasyphylla 
EA extract - - 25 50 100 -
Apigenin (µM) - - - - - 250
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Figure 3 Effect of Payena dasyphylla EA bark fraction on the HYAL1 gene expression in IL-1β stimulated NHAC-kn cells. The gel image
(A) shows the reverse transcriptase-PCR result represented from three independent experiments, while (B) shows the histogram of HYAL1 gene
expression from the same experiment. C; Basal level of HYAL1 gene expression without IL-1β treatment and the rest are cells stimulated with
100 ng/ml human IL-1β with increasing concentrations of sample treatment for 6 hours. Apigenin (250 μM) was used as the positive control.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene expression was used as the loading control. ***P < 0.001 and **P < 0.01 significantly
different from IL-1β treated control group.
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tion of 1 mg/mL prepared in methanol was added to
each well. The plate was then shaken gently and placed
in dark for 30 minutes at room temperature. Ascorbic
acid was used for comparison or as a positive control.
The DPPH solution in the absence of the sample and
contained only methanol was used as control. The ab-
sorbance was then measured at 517 nm using a
microplate reader. Experiments were performed in tripli-
cates. Percentage of DPPH free radical was calculated
using the following equation:




ODcontrol is absorbance from DPPH solution in metha-
nol only and ODsample is absorbance from DPPH solu-
tion treated with different concentration of sample.Phenolic content
The phenolic content of the sample was measured using
Folin-Ciocalteu reagent based on procedure described by
Singleton et al., [17] with some modifications. Stock so-
lution of the sample was prepared at 100 mg/mL. Briefly,
50 μL of the solution was diluted with methanol to ob-
tain the highest concentration 100 μg/mL in a 96-well
microtiter plate. Then, the initial solution was mixed
with 150 μL (1:10 v/v diluted with distilled water) Folin-
Ciocalteau’s reagent and allowed to stand for 5 minutes
at room temperature. Sodium carbonate (Na2CO3, 6%,
w/v) at volume of 150 μL was added and the mixture
was allowed to stand for another 90 min in the dark with
intermittent shaking. The absorbance of the blue colour
that developed was measured at 725 nm using a
microplate reader. The experiment was carried out in
triplicates. Gallic acid was used to construct the standard
curve. A series of gallic acid concentration ranging from
25 μg/mL to 200 μg/mL was prepared in methanol and
the phenolic compounds concentration in the sample
(A)
IL-1β (100 ng/ml) - + + + + +
Payena dasyphylla EA 
fraction (mg/mL)
- - 25 50 100 -
Apigenin (µM) - - - - - 250
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Figure 4 Effect of Payena dasyphylla EA bark fraction on the HYAL2 gene expression in IL-1β stimulated NHAC-kn cells. The gel image
(A) shows the reverse transcriptase-PCR result represented from three independent experiments, while (B) shows the histogram of HYAL2 gene
expression from the same experiment. C; Basal level of HYAL2 gene expression without IL-1β treatment and the rest are cells stimulated with
100 ng/ml human IL-1β with increasing concentrations of sample treatment for 6 hours. Apigenin (250 μM) was used as the positive control.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene expression was used as the loading control. ***P < 0.001, **P < 0.01 and *P < 0.05
significantly different from IL-1β treated control group.
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gram of dry weight (mg GAE/g) of extract.
Flavonoid content
The flavonoid content of the sample was determined
based on procedure described by Zhishen et al., [18]
with some modifications. Stock solution of the sample
was prepared at 100 mg/mL. Briefly, 500 μL of the sam-
ple (100 μg/mL) was mixed with 2 mL of distilled water
in a centrifuge tube. Then, 150 μL of aluminium tri-
chloride (AlCl3, 10% w/v) was added in and the reaction
mixture was allowed to stand for 6 minutes at room
temperature. Next, sodium nitrite (NaNO2, 5% w/v) was
added into the mixture and again was allowed to stand
for 6 minutes, followed by addition of 2 mL of sodium
hydroxide (NaOH, 4% w/v) into the same mixture. Sub-
sequently, distilled water was added to bring the mixture
up to final volume of 5 mL. Later, the reaction mixture
was vortexed thoroughly and allowed to stand for an-
other 15 minutes. The absorbance of pink colour that
developed was measured at 510 nm using a microplate
reader. The experiment was carried out in triplicates.
Rutin was used to plot the standard curve. A series of
rutin concentration ranging from 25 μg/mL to 200 μg/
mL was prepared in methanol and the flavonoid contentin the sample was expressed as milligrams of rutin
equivalent per gram of extract (mg RE/g).
Statistical analysis
The results were expressed as mean ± standard error of
mean (SEM) from three independent experiments. Means
and standard deviations were calculated from the data
obtained and subjected to one-way analysis of variance
(ANOVA) followed by Dunnett’s post-hoc test for multiple
comparison with control. P values <0.05 were considered
significant. The IC50 values were calculated using the stat-
istical software package, GraphPad Prism 5.0 software.
Results and discussion
Screening of anti-hyaluronidase activity
Hyaluronidases have been targeted as one of the pre-
dominant glycosidase that is associated with osteoarth-
ritis (OA) as it participates in the cartilage degradation
mechanism [6]. Therefore, inhibition of hyaluronidase
activity is crucial for normal metabolic processes to take
place. Recent studies on the treatment and prevention of
OA focused on the utility of botanical or natural prod-
ucts which is capable of ameliorating the symptoms of
OA with expectation of limited side effects. Therefore,
a total of ten species of selected Malaysian plants extracted
(A)
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Figure 5 Effect of Payena dasyphylla EA fraction on MMP-3 protein expression in IL-1β-stimulated NHAC-kn cells. The blot image
(A) shown above represents results from three independent experiments while (B) shows the histogram of MMP-3 protein expression from the
same experiment. C; Basal level of MMP-3 expression without IL-1β treatment and the rest are cells stimulated with 10 ng/mL human IL-1β and
treated with increasing concentrations of sample treatment for 24 h. Conditioned-medium were assayed for pretein expression by using Western
blotting. ***P < 0.001 and **P < 0.01 significantly different from IL-1β treated control group.
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for their effect on hyaluronidase inhibitory activity using
bovine testicular hyaluronidase. As presented in Table 1,
the anti-hyaluronidase screening results showed that from
the total of 20 methanolic crude extracts tested, three
plants Palaquium gutta, Pauteria obovatta and Payena
dasyphylla all extracted from the bark showed strong
inhibitory activity against hyaluronidase with 88.82%,
90.47% and 91.63% respectively. This is followed by
Palaquium gutta and Pauteria obovatta derived from the
leaf plus Uncaria villosa from the bark which showed
moderate inhibitory activity with 51.35%, 55.63% and
55.20% respectively. However, other plant extracts stated
only weak inhibitory activity against hyaluronidase. Due to
sample availability and highest inhibitory activity against
hyaluronidase enzyme activity, only Payena dasyphylla
was employed throughout the whole study.
Effect of payena dasyphylla methanolic extract on
hyaluronidase enzyme activity in the cultured human
chondrocyte cells
Chondrocyte cells were shown to exhibit the highest
level of matrix anabolic and catabolic genes and thus,are preferred to be used in investigating chondrocytes
destructive and synthesis activity as well as its regula-
tion [19]. Besides that, human and bovine chondrocytes
are the only cells present in articular cartilage that ex-
press hyaluronidases [15,20,21]. In this study, the effect
of P. dasyphylla methanolic bark extract on cellular hy-
aluronidase expression was evaluated on the cultured
human chondrocyte cell line (NHAC-kn). To mimic
the degenerative effect of osteoarthritic cartilage, the
cells were induced with human interleukin-1β (IL-1β).
IL-1β is a pro-inflammatory cytokine that interferes
with the extracellular matrix turnover by accelerating
the degradation of cartilage matrix and inducing chon-
drocytes apoptosis. Results revealed that P. dasyphylla
methanolic bark crude extract suppressed the hyal-
uronidase expression in the IL-1β stimulated chon-
droytes culture in a dose-dependent manner. This was
observed through the decolouration (white band) of the
blue background of the gel (Figure 1). Apigenin, a
known hyaluronidase inhibitor in vitro was used as the
positive control. Experimentally, this study demon-
strates that treatment with human IL-1β has dramatic-
ally enhanced HA catabolism and treatment with
(A)
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Figure 6 Effect of Payena dasyphylla EA fraction on MMP-13 protein expression in IL-1β-stimulated NHAC-kn cells. The blot image
(A) shown above represents results from three independent experiments while (B) shows the histogram of MMP-13 protein expression from the
same experiment. C; Basal level of MMP-13 expression without IL-1β treatment and the rest are cells stimulated with 10 ng/mL human IL-1β and
treated with increasing concentrations of sample treatment for 24 h. Conditioned-medium were assayed for pretein expression by using Western
blotting. ***P < 0.001 and **P < 0.01 significantly different from IL-1β treated control group.
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expression from further degradation of HA.
Since P. dasyphylla methanolic crude extract showed
effective in inhibiting hyaluronidase expression, it was
thought worthwhile to fractionate the crude methanolic
extract into several fractions based on the polarity of the
compounds containing in the extract. P. dasyphylla
crude extract was fractionated into three fractions using
different range of solvents (water, ethyl acetate and hex-
ane) whereby all the fractions were tested for its hyal-
uronidase inhibitory activity. It is determined that from
the three fractions tested, Water fraction stated the
highest inhibitory activity against hyaluronidase enzyme,
followed by ethyl acetate (EA) fraction, and lastly the
hexane fraction (results not shown). However, only EA
fraction was chosen to be further evaluated on its effect
toward the hyaluronidase enzyme. This is because,
P. dasyphylla from the family of Sapotacea has been
reported to contain high concentration of polyphenols
such as tannins which usually contain in the water frac-
tion and tannins are known to form complexes with a
variety of proteins which may result in false positive re-
sults [22].Cytotoxicity effect of Payena dasyphylla bark extracts
Nevertheless, the methanolic and EA fractions of
P.dasyphylla were tested for their toxicity effect on the
NHAC-kn cells induced with IL-1β. Results showed that
both the extracts did not show any concomitant effect on
the cells at all concentrations (Figure 2). In certain con-
centrations, the percentage of cell viability showed higher
than 100% which could be due to the presence of bioactive
principles in the extract that might have induced the pro-
liferative effect of the cells [23]. Besides, it could also be
due to nonuniform density of cell number at certain wells
which could have affected the cell viability.
Effect of Payena dasyphylla ethyl acetate (EA) fraction on
the HYAL1 and HYAL2 mRNA gene expression
It has been proposed that hyaluronan or hyaluronic acid
(HA) catabolism occurs in a stepwise manner in where HA
is first cleaved by Hyal2 into 20 kDa fragments which are
then delivered into lysosomes for further degradation by
Hyal1 and lysosomal β-exoglycosidases [24]. In order to de-
termine whether Payena dasyphylla EA extract was able to
inhibit the mRNA expression of the two principle hyal-
uronidases (HYAL1 and HYAL2), RT-PCR analysis was

























Figure 7 Effect of Payena dasyphylla EA fraction and ascorbic
acid on the antioxidant activity. P. dasyphylla showed 82.19%
radical scavenging activity at highest concentration tested
(100 μg/mL) with IC50 value of 11.64 ± 1.69 μg/mL. Whereas,
ascorbic acid exhibited antioxidant activity at 86.68% (100 μg/mL)
with IC50 value of 4.03 ± 0.24 μg/mL.








Ethyl acetate 168.62 ± 10.93 95.96 ± 2.96
Water 84.32 ± 3.89 20.63 ± 0.87
Hexane 0.45 ± 0.02 -
Values are expressed as means ± SD of three independent experiments. aGAE
(gallic acid equivalents) and bRE (Rutin equivalents).
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sults showed that P. dasyphylla inhibited the both genes,
HYAL1 and HYAL2 in a dose dependent manner. Stimula-
tion with IL-1β has up-regulated the gene expression of
HYAL1 (Figure 3) whereas for the case of HYAL2 gene ex-
pression, there were notably little changes in the level of
expression following treatment with IL-1β (Figure 4). This
is because, HYAL2 being predominantly expressed gene in
the chondrocytes is showed to be constitutively expressed
[21]. Therefore, stimulation with the inducer resulted in no
remarkable changes in the expression. However, results
from both the mRNA expression of the hyaluronidases
shows that HYAL1 and HYAL2 are up-regulated by the
treatment of IL-1β. This is in accordance with the study
done by Nakamura et al., [25]. Findings from this data
demonstrates that treatment with P. dasyphylla EA extract
in response to human IL-1β has proven to be potential
inhibiting the two principle hyaluronidases.
Effect of Payena dasyphylla EA fraction on the MMP-3 and
MMP-13 protein expression
Although hyaluronidases have been found to be the tar-
get enzyme in the development of osteoarthritic disease,
studies have reported that MMPs also play a significant
role in the destruction of the cartilage matrix in osteo-
arthritis [26]. MMP-3 and MMP-13 has assumed greater
importance in OA because of its presence in human OA
cartilage [27,28]. MMP-13 (collagenase) preferential de-
grades type II collagen whereas MMP-3 (stromelysin) de-
grades matrix components leading to the cleavage of
collagen and proteoglycans [10,29,30]. Thus, the inhibitory
effect of P. dayphylla EA extract on these two mediators
was examined. Conditioned culture media derived from
NHAC-kn cells treated with human IL-1β inducer showed
that activated cells produced MMP-3 and MMP-13 pro-
tein expression [31,32]. Results showed that, in contrast to
uninduced cells, no MMP bands were observed. However,
treatment with P. dasyphylla EA extract in response to
stimulation with human IL-1β inhibited the MMP-3 and
MMP-13 expression suggesting that this plant extract is
not selectively effective towards hyaluronidases, but is
also potential against MMP-3 and MMP-13 expression
(Figure 5 and Figure 6). Through IL-1β stimulation,
MMPs production is significantly increased as this cyto-
kine is involved in triggering the catabolism of cartilage
degeneration. This finding is in agreement with other
research done on rabbit and human femoral head
chondrocytes where IL-1β was shown to induce expres-
sion of MMP proteins [29,31-35].
Antioxidant capacity of Payena dasyphylla EA extract
Phenolic and flavonoid compounds are known secondary
metabolites that are synthesized in plants. They are
commonly found in both edible and inedible plants andhave been reported to possess important biological ef-
fects such as antioxidant, anti-apoptosis, anti-aging,
anticarcinogen, anti-inflammation, anti-artherosclerosis
as well as inhibition of angiogenesis and cell prolifera-
tion [35-37]. Results showed that P. dasyphylla EA frac-
tion showed the highest amount of phenolic and
flavonoid content as compared to water and hexane frac-
tions (Table 2). Whereas hexane fraction did not show
any traces of flavonoid content. These results were con-
sistent with other findings which had reported that hex-
anes (non-polar solvent) as well as water (polar solvent)
were less efficient to extract phenolic compounds from
plants [38-40]. Since flavonoid compounds have been
reported to be potent metal chelators and free radical
scavengers [41-44], the antioxidant capacity of this ex-
tract was also evaluated. Results showed that, at the
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82.19% antioxidant radical scavenging activity with IC50
value of 11.64 ± 1.69 μg/mL. Ascorbic acid, a potent free
radical scavenger was used as a positive control at a con-
centration of 100 μg/mL, exhibited 86.68% antioxidant
activity with IC50 value of 4.03 ± 0.24 μg/mL (Figure 7).
P. dasyphylla EA extract contained strong antioxidant
property but not as high as compared to ascorbic acid, a
known antioxidant. Studies have shown that free radicals
play a part in promoting cartilage degradation in osteo-
arthritis [45]. Therefore, these finding suggested that
phenolic compounds or flavonoids present in the frac-
tion may have acted as the metal chelators responsible
for its antioxidant activity.
Conclusion
Payena dasyphylla is a local plant that has been exten-
sively used in the timber industry. Till date, there have not
been any studies reporting on its usage in the biomedical
field. Our present study had demonstrated that P.
dasyphylla possessed anti-arthritic property by inhibiting
hyaluronidase enzyme activity and/expression by down
regulating HYAL1 and HYAL2 gene expressions as well as
MMP-3 and MMP-13 protein expressions in human
chondrocytes cell line. In addition to its inhibitory effect,
the ethyl acetate (EA) fraction of P. dasyphylla showed
high content of phenolic or flavonoids which could be re-
lated to its radical scavenging power. Inhibition of these
specific targets helps to restore and maintain the articular
cartilage from further destruction in osteoarthritis. This
knowledge may be useful for developing novel therapies
for blocking IL-1β stimulated cartilage breakdown in
osteoarthritis.
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